IBDEI0PS ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12349,1,3,0)
 ;;=3^V16.41
 ;;^UTILITY(U,$J,358.3,12349,1,4,0)
 ;;=4^Fam HX, Malig Neopl of Ovary
 ;;^UTILITY(U,$J,358.3,12349,2)
 ;;=^317951
 ;;^UTILITY(U,$J,358.3,12350,0)
 ;;=625.6^^62^738^43
 ;;^UTILITY(U,$J,358.3,12350,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12350,1,3,0)
 ;;=3^625.6
 ;;^UTILITY(U,$J,358.3,12350,1,4,0)
 ;;=4^Fem Stress Incontinence
 ;;^UTILITY(U,$J,358.3,12350,2)
 ;;=^114717
 ;;^UTILITY(U,$J,358.3,12351,0)
 ;;=V53.99^^62^738^46
 ;;^UTILITY(U,$J,358.3,12351,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12351,1,3,0)
 ;;=3^V53.99
 ;;^UTILITY(U,$J,358.3,12351,1,4,0)
 ;;=4^Fit/Adjust Device NEC
 ;;^UTILITY(U,$J,358.3,12351,2)
 ;;=^329974
 ;;^UTILITY(U,$J,358.3,12352,0)
 ;;=611.71^^62^738^57
 ;;^UTILITY(U,$J,358.3,12352,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12352,1,3,0)
 ;;=3^611.71
 ;;^UTILITY(U,$J,358.3,12352,1,4,0)
 ;;=4^Mastodynia
 ;;^UTILITY(U,$J,358.3,12352,2)
 ;;=^74467
 ;;^UTILITY(U,$J,358.3,12353,0)
 ;;=622.7^^62^738^60
 ;;^UTILITY(U,$J,358.3,12353,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12353,1,3,0)
 ;;=3^622.7
 ;;^UTILITY(U,$J,358.3,12353,1,4,0)
 ;;=4^Mucous Polyp of Cervix
 ;;^UTILITY(U,$J,358.3,12353,2)
 ;;=^79612
 ;;^UTILITY(U,$J,358.3,12354,0)
 ;;=795.02^^62^738^65
 ;;^UTILITY(U,$J,358.3,12354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12354,1,3,0)
 ;;=3^795.02
 ;;^UTILITY(U,$J,358.3,12354,1,4,0)
 ;;=4^Pap Smear (ASC-H)
 ;;^UTILITY(U,$J,358.3,12354,2)
 ;;=^331973
 ;;^UTILITY(U,$J,358.3,12355,0)
 ;;=795.01^^62^738^66
 ;;^UTILITY(U,$J,358.3,12355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12355,1,3,0)
 ;;=3^795.01
 ;;^UTILITY(U,$J,358.3,12355,1,4,0)
 ;;=4^Pap Smear (ASC-US)
 ;;^UTILITY(U,$J,358.3,12355,2)
 ;;=^331972
 ;;^UTILITY(U,$J,358.3,12356,0)
 ;;=795.04^^62^738^67
 ;;^UTILITY(U,$J,358.3,12356,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12356,1,3,0)
 ;;=3^795.04
 ;;^UTILITY(U,$J,358.3,12356,1,4,0)
 ;;=4^Pap Smear Cervix w/ HGSIL
 ;;^UTILITY(U,$J,358.3,12356,2)
 ;;=^331572
 ;;^UTILITY(U,$J,358.3,12357,0)
 ;;=795.03^^62^738^68
 ;;^UTILITY(U,$J,358.3,12357,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12357,1,3,0)
 ;;=3^795.03
 ;;^UTILITY(U,$J,358.3,12357,1,4,0)
 ;;=4^Pap Smear Cervix w/ LGSIL
 ;;^UTILITY(U,$J,358.3,12357,2)
 ;;=^331571
 ;;^UTILITY(U,$J,358.3,12358,0)
 ;;=256.4^^62^738^73
 ;;^UTILITY(U,$J,358.3,12358,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12358,1,3,0)
 ;;=3^256.4
 ;;^UTILITY(U,$J,358.3,12358,1,4,0)
 ;;=4^Polycystic Ovaries
 ;;^UTILITY(U,$J,358.3,12358,2)
 ;;=^96086
 ;;^UTILITY(U,$J,358.3,12359,0)
 ;;=627.0^^62^738^78
 ;;^UTILITY(U,$J,358.3,12359,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12359,1,3,0)
 ;;=3^627.0
 ;;^UTILITY(U,$J,358.3,12359,1,4,0)
 ;;=4^Premenopause Menorrhagia
 ;;^UTILITY(U,$J,358.3,12359,2)
 ;;=^270575
 ;;^UTILITY(U,$J,358.3,12360,0)
 ;;=V45.51^^62^738^80
 ;;^UTILITY(U,$J,358.3,12360,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12360,1,3,0)
 ;;=3^V45.51
 ;;^UTILITY(U,$J,358.3,12360,1,4,0)
 ;;=4^Presence of IUD
 ;;^UTILITY(U,$J,358.3,12360,2)
 ;;=^98125
 ;;^UTILITY(U,$J,358.3,12361,0)
 ;;=618.04^^62^738^81
 ;;^UTILITY(U,$J,358.3,12361,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12361,1,3,0)
 ;;=3^618.04
 ;;^UTILITY(U,$J,358.3,12361,1,4,0)
 ;;=4^Rectocele
 ;;^UTILITY(U,$J,358.3,12361,2)
 ;;=^259590
 ;;^UTILITY(U,$J,358.3,12362,0)
 ;;=V76.2^^62^738^84
 ;;^UTILITY(U,$J,358.3,12362,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12362,1,3,0)
 ;;=3^V76.2
 ;;^UTILITY(U,$J,358.3,12362,1,4,0)
 ;;=4^Screen Mal Neop-Cervix
 ;;^UTILITY(U,$J,358.3,12362,2)
 ;;=^295653
 ;;^UTILITY(U,$J,358.3,12363,0)
 ;;=V76.10^^62^738^85
 ;;
 ;;$END ROU IBDEI0PS
